44.44
price down icon4.43%   -2.06
after-market Handel nachbörslich: 44.45 0.01 +0.02%
loading

Finanzdaten der Protagonist Therapeutics Inc-Aktie (PTGX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
324.92%
254.95
60.00 - - -
Operating Expenses
31.64%
48.64
36.95 38.33 42.35 36.02
Benefits Costs and Expenses
44.29
- - - -
Costs And Expenses
44.29
- - - -
Operating Income/Loss
795.09%
206.31
23.05 -38.33 -42.35 -36.02
Income/Loss From Continuing Operations Before Tax
670.68%
210.67
27.34 -34.10 -38.46 -33.73
Income Tax Expense/Benefit
3.326
- - - -
Income/Loss From Continuing Operations After Tax
658.51%
207.34
27.34 -34.10 -38.46 -33.73
Net Income/Loss
658.51%
207.34
27.34 -34.10 -38.46 -33.73
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4,884%
60.86
1.221 59.18 56.78 50.57
Diluted Average Shares
5,108%
63.60
1.221 59.18 56.78 50.57
Basic Earnings Per Share
555.77%
3.41
0.52 -0.58 -0.68 -0.67
Diluted Earnings Per Share
526.92%
3.26
0.52 -0.58 -0.68 -0.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):